Overview

Clinical Nutrition Market is poised to register a CAGR of 6.1% during the forecast period 2022 to 2028. 

FutureWise Market Research has instantiated a report that provides an intricate analysis of Clinical Nutrition Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Clinical Nutrition Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Clinical Nutrition Market:
• Abbott Nutrition
• B Braun Melsungen Ag
• BASF SE
• Baxter International Inc.
• Claris Lifesciences Ltd.
• Fresenius Kabi Ag
• Lonza Group AG
• Nestle Health Science
• Nutricia Ltd
• Perrigo Company Plc
• Pfizer Inc.
• GlaxoSmithKline
• Mead Johnson
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Clinical Nutrition Market Segmentation:
By Substrate
• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants
• Other Substrates
By Administration Route
• Oral or Enteral Administration
      o Oral Nutrition Supplements
      o Tube Feeding
• Parenteral Administration
     o Supplemental Parenteral Nutrition
     o Total Parenteral Nutrition
     o All-in-One System
     o Multiple Bottle System
By End User
• Infant
• Children
• Adult
• Geriatrics
By Therapeutic Area
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Cancer
• Neurology
• Renal Diseases
• Respiratory Diseases
• Other Therapeutic Areas
By Healthcare Setting
• Hospitals
• Long-term Care Facilities (LTC)
• Homecare
• Inpatient Rehabilitation Facilities
• Other Healthcare Settings
By Distribution Channel
• Institutional Sales
• Supermarkets & Hypermarkets
• Pharmacies
• Drug Stores
• Online Channels
• Other Distribution Channels
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Clinical Nutrition Market By Substrate, By Administration Route, By End User, By Therapeutic Area,  By Healthcare Setting, By Distribution Channel and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Clinical Nutrition Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Clinical Nutrition Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Clinical Nutrition Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Clinical Nutrition Market, By Substrate Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Carbohydrates
  7.2. Lipids
  7.3. Proteins & Amino Acids
  7.4. Water & Electrolyte
  7.5. Dietary Fiber
  7.6. Antioxidants
  7.7. Other Substrates

8. Clinical Nutrition Market, By Administration Route Historical Analysis and Forecast 2022-2028 (USD Million)
  8.1. Oral or Enteral Administration
       8.1.1. Oral Nutrition Supplements
       8.1.2. Tube Feeding
  8.2. Parenteral Administration
       8.2.1. Supplemental Parenteral Nutrition
       8.2.2. Total Parenteral Nutrition
       8.2.3. All-in-One System
       8.2.4. Multiple Bottle System

9. Clinical Nutrition Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
  9.1. Infant
  9.2. Children
  9.3. Adult
  9.4. Geriatrics

10. Clinical Nutrition Market, By Therapeutic Area Historical Analysis and Forecast 2022-2028 (USD Million)
  10.1. Malnutrition
  10.2. Metabolic Disorders
  10.3. Gastrointestinal Disorders
  10.4. Cancer
  10.5. Neurology
  10.6. Renal Diseases
  10.7. Respiratory Diseases
  10.8. Other Therapeutic Areas

11. Clinical Nutrition Market, By Healthcare Setting Historical Analysis and Forecast 2022-2028 (USD Million)
  11.1. Hospitals
  11.2. Long-term Care Facilities (LTC)
  11.3. Homecare
  11.4. Inpatient Rehabilitation Facilities
  11.5. Other Healthcare Settings

12. Clinical Nutrition Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million)
  12.1. Institutional Sales
  12.2. Supermarkets & Hypermarkets
  12.3. Pharmacies
  12.4. Drug Stores
  12.5. Online Channels
  12.6. Other Distribution Channels

13. North America Clinical Nutrition Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
  13.1. Introduction
  13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
       13.2.1. U.S.A
       13.2.2. Canada
       13.2.3. Mexico
  13.3. Market Size (USD Million) Forecast for North America 2022-2028

14. Latin America Clinical Nutrition Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. Brazil
         14.2.2. Venezuela
         14.2.3. Argentina
         14.2.4. Rest of Latin America
   14.3. Market Size (USD Million) Forecast for Latin America 2022-2028

15. Europe Clinical Nutrition Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         15.2.1. Germany
         15.2.2. U.K        
         15.2.3. France
         15.2.4. Italy
         15.2.5. Spain
         15.2.6. Russia
         15.2.7. Poland
         15.2.8. Rest of Europe
   15.3. Market Size (USD Million) Forecast for Europe 2022-2028

16. Asia Pacific Clinical Nutrition Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         16.2.1. Japan
         16.2.2. China
         16.2.3. India
         16.2.4. Australia and New Zealand
         16.2.5. ASEAN
         16.2.6. Rest of Asia Pacific
   16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
   17.1. Introduction
   17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         17.2.1. GCC
         17.2.2. Israel
         17.2.3. South Africa
         17.2.4. Rest of MEA
   17.3. Market Size (USD Million) Forecast for MEA 2022-2028

18. Market Share Analysis and Competitive Landscape  
   18.1. Global Landscape - Key Players, Revenue and Presence
   18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   18.3. Global Emerging Companies
   18.4.  North America - Market Share Analysis and Key Regional Players
   18.5.  Europe - Market Share Analysis and Key Regional Players
   18.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   18.7.  Global Key Player - Growth Matrix

19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   19.1. Abbott Nutrition
         19.1.1. Company Overview
         19.1.2. Product Portfolio
         19.1.3. SWOT Analysis
         19.1.4. Financial Overview
         19.1.5. Strategic Overview
   19.2. B Braun Melsungen Ag
         19.2.1. Company Overview
         19.2.2. Product Portfolio
         19.2.3. SWOT Analysis
         19.2.4. Financial Overview
         19.2.5. Strategic Overview
   19.3. BASF SE
         19.3.1. Company Overview
         19.3.2. Product Portfolio
         19.3.3. SWOT Analysis
         19.3.4. Financial Overview
         19.3.5. Strategic Overview
   19.4. Baxter International Inc.
         19.4.1. Company Overview
         19.4.2. Product Portfolio
         19.4.3. SWOT Analysis
         19.4.4. Financial Overview
         19.4.5. Strategic Overview
   19.5. Claris Lifesciences Ltd.
         19.5.1. Company Overview
         19.5.2. Product Portfolio
         19.5.3. SWOT Analysis
         19.5.4. Financial Overview
         19.5.5. Strategic Overview          
   19.6. Fresenius Kabi Ag
         19.6.1. Company Overview
         19.6.2. Product Portfolio
         19.6.3. SWOT Analysis
         19.6.4. Financial Overview
         19.6.5. Strategic Overview      
   19.7. Lonza Group AG
         19.7.1. Company Overview
         19.7.2. Product Portfolio
         19.7.3. SWOT Analysis
         19.7.4. Financial Overview
         19.7.5. Strategic Overview
   19.8. Nestle Health Science
         19.8.1. Company Overview
         19.8.2. Product Portfolio
         19.8.3. SWOT Analysis
         19.8.4. Financial Overview
         19.8.5. Strategic Overview
   19.9. Nutricia Ltd
         19.9.1. Company Overview
         19.9.2. Product Portfolio
         19.9.3. SWOT Analysis
         19.9.4. Financial Overview
         19.9.5. Strategic Overview
   19.10.Perrigo Company Plc
         19.10.1. Company Overview
         19.10.2. Product Portfolio
         19.10.3. SWOT Analysis
         19.10.4. Financial Overview
         19.10.5. Strategic Overview
   19.11.Pfizer Inc.
         19.11.1. Company Overview
         19.11.2. Product Portfolio
         19.11.3. SWOT Analysis
         19.11.4. Financial Overview
         19.11.5. Strategic Overview
   19.12.GlaxoSmithKline
         19.12.1. Company Overview
         19.12.2. Product Portfolio
         19.12.3. SWOT Analysis
         19.12.4. Financial Overview
         19.12.5. Strategic Overview
   19.13.Mead Johnson
         19.13.1. Company Overview
         19.13.2. Product Portfolio
         19.13.3. SWOT Analysis
         19.13.4. Financial Overview
         19.13.5. Strategic Overview

20. Pre and Post COVID-19 Impact
   20.1. Positive influence on the healthcare industry
   20.2. The financial disruption of the manufacturing sector
   20.3. Impact of COVID-19 on emerging companies
   20.4. Significant mandates in the healthcare regulations initiated by administrations
   20.5. The overall economic slowdown of the developing and developed nations

21. FutureWise SME Key Takeaway Points for Client

Tables

Figures